id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-N-1741-0001,FDA,FDA-2014-N-1741,"Proposed Criteria for ""First Generic"" Submissions for Purposes of Abbreviated New Drug Application Review Prioritization Under the Generic Drug User Fee Amendments",Notice,Request for Comments,2014-11-19T05:00:00Z,2014,11,2014-11-19T05:00:00Z,2014-12-20T04:59:59Z,2014-12-20T03:00:43Z,2014-27385,0,0,0900006481937e0a